Variant report
Variant | nsv823061 |
---|---|
Chromosome Location | chr5:42628878-42631089 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568731218 | chr5:42628880-42628881 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs535928762 | chr5:42628992-42628993 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs369825370 | chr5:42629104-42629105 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs373055838 | chr5:42629142-42629143 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs143287692 | chr5:42629151-42629152 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs377297987 | chr5:42629167-42629168 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs76183160 | chr5:42629168-42629169 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs121909370 | chr5:42629171-42629172 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs181298988 | chr5:42629188-42629189 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371117905 | chr5:42629206-42629207 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs558277834 | chr5:42629276-42629277 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs578161633 | chr5:42629308-42629309 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs545400213 | chr5:42629312-42629313 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs185523882 | chr5:42629322-42629323 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs575943034 | chr5:42629519-42629520 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs531022288 | chr5:42629567-42629568 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs190380365 | chr5:42629592-42629593 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs141947004 | chr5:42629601-42629602 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs72754957 | chr5:42629613-42629614 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs540578073 | chr5:42629631-42629632 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs182890613 | chr5:42629682-42629683 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs376777799 | chr5:42629730-42629731 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs187158825 | chr5:42629810-42629811 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs550475088 | chr5:42629837-42629838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs35936468 | chr5:42629890-42629891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs561446034 | chr5:42629916-42629917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs528811741 | chr5:42629942-42629943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs56172046 | chr5:42629998-42629999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs192511664 | chr5:42630028-42630029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs138715694 | chr5:42630062-42630063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs148839200 | chr5:42630138-42630139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs143498670 | chr5:42630150-42630151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533654944 | chr5:42630228-42630229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558498731 | chr5:42630291-42630292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182497255 | chr5:42630302-42630303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs539304393 | chr5:42630413-42630414 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs557714012 | chr5:42630443-42630444 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs546642707 | chr5:42630444-42630445 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs367888447 | chr5:42630483-42630484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs575904984 | chr5:42630600-42630601 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs148026285 | chr5:42630622-42630623 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs141742782 | chr5:42630624-42630625 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs369465313 | chr5:42630691-42630692 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs573240028 | chr5:42630709-42630710 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs142354464 | chr5:42630761-42630762 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs188003809 | chr5:42630825-42630826 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs565246742 | chr5:42630867-42630868 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs146025739 | chr5:42630884-42630885 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs544099926 | chr5:42630891-42630892 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs55749721 | chr5:42630984-42630985 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Breast cancer | 21364760 | CNVD |
Intellectual disability | 21811512 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Attention deficit hyperactivity disorder | 19546859 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:42621800-42629000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr5:42622800-42631200 | Weak transcription | Adipose Nuclei | Adipose |
3 | chr5:42623000-42631400 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
4 | chr5:42623000-42644400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr5:42623200-42631400 | Weak transcription | Right Atrium | heart |
6 | chr5:42623800-42632000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
7 | chr5:42624400-42629400 | Weak transcription | Primary B cells from peripheral blood | blood |
8 | chr5:42624600-42648000 | Weak transcription | Fetal Lung | lung |
9 | chr5:42626600-42632600 | Weak transcription | Aorta | Aorta |
10 | chr5:42626800-42631600 | Weak transcription | Placenta | Placenta |
11 | chr5:42627200-42632200 | Weak transcription | Ovary | ovary |
12 | chr5:42628200-42631400 | Weak transcription | Left Ventricle | heart |
13 | chr5:42628400-42630400 | Weak transcription | Fetal Heart | heart |
14 | chr5:42628400-42631400 | Weak transcription | Liver | Liver |
15 | chr5:42628400-42631400 | Weak transcription | Psoas Muscle | Psoas |
16 | chr5:42628400-42631400 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
17 | chr5:42628400-42632000 | Weak transcription | Esophagus | oesophagus |
18 | chr5:42628800-42629200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
19 | chr5:42629000-42629800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr5:42629200-42639600 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
21 | chr5:42629400-42629800 | Enhancers | Primary B cells from peripheral blood | blood |
22 | chr5:42629800-42631400 | Weak transcription | Primary B cells from peripheral blood | blood |
23 | chr5:42629800-42637600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
24 | chr5:42630400-42634600 | Enhancers | Fetal Heart | heart |